Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,244.00
Bid: 4,244.00
Ask: 4,245.00
Change: 32.00 (0.76%)
Spread: 1.00 (0.024%)
Open: 4,225.00
High: 4,245.00
Low: 4,222.00
Prev. Close: 4,212.00
ULVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Unilever’s Unification

30 Nov 2020 07:00

RNS Number : 8358G
Unilever PLC
30 November 2020
 

Completion of Unilever's Unification

 

30 November 2020

 

Unilever is pleased to announce the completion of the unification of its Group legal structure under a single parent company, Unilever PLC.

 

From today, and for the first time in its history, Unilever now trades with one market capitalisation, one class of shares and one global pool of liquidity, whilst also maintaining the Group's listings on the Amsterdam, London and New York stock exchanges.

 

Nils Andersen, Chairman of Unilever, said: "This is an important day for Unilever and we would like to thank our shareholders for their strong support of our Unification proposals, which give us greater flexibility for strategic portfolio change, remove complexity and further improve governance."

 

There will be no change to the operations, locations, activities or staffing levels in either The Netherlands or the United Kingdom as a result of Unification. The headquarters of Unilever's Foods & Refreshment Division will continue to be based in Rotterdam and the Home Care and Beauty & Personal Care Divisions will continue to be headquartered in the United Kingdom.

 

Further information for shareholders

 

Dealings in new Unilever PLC shares commence today on the London Stock Exchange, Euronext Amsterdam and the New York Stock Exchange.

 

New Unilever PLC shares will be admitted to the Premium Listing segment of the Official List of the UK Financial Conduct Authority ("FCA") and to trading on the London Stock Exchange's Main Market for listed securities with the ticker "ULVR" this morning. Unilever PLC shares will also be admitted to listing and to trading on Euronext in Amsterdam, a regulated market of Euronext Amsterdam N.V., under the ticker "UNA" this morning. It is expected that Unilever PLC ADSs will be admitted to trading on the New York Stock Exchange this afternoon.

 

Following the issue and allotment of 1,460,713,122 new Unilever PLC shares pursuant to Unification, which represent 55.56% of the total number of PLC shares, Unilever PLC's total issued ordinary share capital consists today of 2,629,243,772 ordinary shares of 3 1/9 pence each.

 

As part of Unification, Unilever NV ceased to exist yesterday, 29 November 2020, as a result of which there have been no dealings, and will be no further dealings, in any Unilever NV securities (including in Unilever NV shares on Euronext in Amsterdam) since that date.

 

Unilever PLC holds no ordinary shares in treasury. As at today's date, 1,383,237 Unilever PLC shares (including Unilever PLC shares represented by Unilever PLC ADSs) are held by companies in the Unilever Group. The voting rights attaching to those shares are not exercisable. Therefore, the total number of shares with exercisable voting rights in Unilever PLC is 2,627,860,535. This figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in Unilever PLC under the FCA's Disclosure Guidance and Transparency Rules. As at today's date, shareholders of Unilever PLC do not have similar notification obligations under applicable Dutch law.

 

 

Enquiries

Unilever PLC

Unilever House

100 Victoria Embankment

London EC4Y 0DY

United Kingdom

 

 

Media: Media Relations team

 

UK

+44 78 2527 3767

lucila.zambrano@unilever.com

+44 77 7999 9683

JSibun@tulchangroup.com

Investors: Investor Relations team

 

+44 20 7822 6830

investor.relations@unilever.com

 

NL

+31 10 217 4844 els-de.bruin@unilever.com

+31 62 375 8385 marlous-den.bieman@unilever.com

 

 

SAFE HARBOUR

This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995. Words such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the "Group" or "Unilever"). They are not historical facts, nor are they guarantees of future performance. Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are: Unilever's global brands not meeting consumer preferences; Unilever's ability to innovate and remain competitive; Unilever's investment choices in its portfolio management; the effect of climate change on Unilever's business; Unilever's ability to find sustainable solutions to its plastic packaging; significant changes or deterioration in customer relationships; the recruitment and retention of talented employees; disruptions in our supply chain and distribution; increases or volatility in the cost of raw materials and commodities; the production of safe and high quality products; secure and reliable IT infrastructure; execution of acquisitions, divestitures and business transformation projects; economic, social and political risks and natural disasters; financial risks; failure to meet high and ethical standards; and managing regulatory, tax and legal matters. A number of these risks have increased as a result of the current COVID-19 pandemic. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission (the "SEC"), including in the Annual Report on Form 20-F 2019 and the Unilever Annual Report and Accounts 2019.

 

 

IMPORTANT INFORMATION

This communication is for informational purposes only and does not constitute or form part of an offer to sell or the solicitation of an offer to buy or subscribe to any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This communication is not an offer of securities for sale into the United States. No offering of securities shall be made in the United States except pursuant to registration under the US Securities Act of 1933 (the "Securities Act"), or an exemption therefrom. In connection with Unification, Unilever PLC has issued ordinary shares (including ordinary shares represented by American Depositary Shares) to security holders of Unilever N.V. in reliance upon the exemption from the registration requirements of the Securities Act provided by Section 3(a)(10) thereof. Unification has not been and will not be approved or disapproved by the SEC, nor has the SEC or any US state securities commission passed upon the merits or fairness of Unification. Any representation to the contrary is a criminal offence in the United States.

 

The release, publication or distribution of this communication in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this communication is released, published or distributed should inform themselves about and observe such restrictions.

 

This communication does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase. It is not an advertisement and not a prospectus for the purposes of Regulation (EU) No. 2017/1129, as amended. Any purchase of securities of Unilever PLC should only be made on the basis of information that is contained in the Prospectus published by Unilever PLC on 10 August 2020 (the "Prospectus"). The Prospectus contains detailed information about Unilever PLC and its management, as well as financial statements and other financial data. A copy of the Prospectus is available on the website of the Unilever Group at www.unilever.com/unification/documents. It may be unlawful to distribute these materials in certain jurisdictions. References to information and/or documents that are available on the Unilever Group's website are included in this announcement as an aid to their location. Such information or the contents of any such documents are not incorporated by reference in, and do not form part of, this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPGCGGUPUGGB
Date   Source Headline
1st May 20244:10 pmRNSResult of AGM
1st May 20243:17 pmRNSCommittee Composition
1st May 20249:06 amRNSTotal Voting Rights
25th Apr 20247:00 amRNSQ1 2024 Trading Statement
2nd Apr 20243:58 pmRNSTotal Voting Rights
28th Mar 20245:04 pmRNSDirector/PDMR Shareholding
27th Mar 202412:32 pmRNSDirector/PDMR Shareholding
26th Mar 20246:13 pmRNSDirector/PDMR Shareholding
26th Mar 202411:58 amRNSDirector/PDMR Shareholding
25th Mar 20243:10 pmRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSUnilever to accelerate Growth Action Plan
18th Mar 20243:00 pmRNSNotice of AGM
14th Mar 20242:14 pmRNSAnnual Financial Report
13th Mar 20247:00 amRNSBlock Listing of Shares
11th Mar 20245:55 pmRNSDirector/PDMR Shareholding
1st Mar 20242:36 pmRNSTotal Voting Rights
19th Feb 20243:14 pmRNSDirector/PDMR Shareholding
8th Feb 20247:00 amRNSFinal Results
1st Feb 20245:04 pmRNSTotal Voting Rights
31st Jan 20243:00 pmRNSDirectorate Change
16th Jan 20245:10 pmRNSBlock listing Interim Review
2nd Jan 20242:54 pmRNSTotal Voting Rights
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
15th Dec 20235:48 pmRNSDirector/PDMR Shareholding
12th Dec 20235:51 pmRNSDirector/PDMR Shareholding
11th Dec 20235:48 pmRNSDirector/PDMR Shareholding
11th Dec 20235:43 pmRNSDirector/PDMR Shareholding
4th Dec 20235:28 pmRNSTotal Voting Rights
23rd Nov 20233:51 pmRNSDirector/PDMR Shareholding
22nd Nov 20235:44 pmRNSDirector/PDMR Shareholding
10th Nov 20235:33 pmRNSDirector/PDMR Shareholding
8th Nov 20236:05 pmRNSDirector/PDMR Shareholding
1st Nov 20233:36 pmRNSTotal Voting Rights
30th Oct 20234:33 pmRNSStatement re Director Remuneration Report AGM Vote
26th Oct 20237:01 amRNSUnilever Announces New CFO
26th Oct 20237:00 amRNS3rd Quarter Results
18th Oct 20232:00 pmRNSCompletion of the 4th Tranche Share Buyback
17th Oct 20235:57 pmRNSTransaction in Own Shares
16th Oct 20236:01 pmRNSTransaction in Own Shares
13th Oct 20235:58 pmRNSTransaction in Own Shares
12th Oct 20235:50 pmRNSTransaction in Own Shares
12th Oct 20239:04 amRNSChanges to Membership of Board Committees
11th Oct 20236:06 pmRNSTransaction in Own Shares
11th Oct 20234:37 pmRNSDirector/PDMR Shareholding
10th Oct 20235:42 pmRNSTransaction in Own Shares
9th Oct 20236:05 pmRNSTransaction in Own Shares
6th Oct 20235:55 pmRNSTransaction in Own Shares
5th Oct 20235:46 pmRNSTransaction in Own Shares
4th Oct 20235:54 pmRNSTransaction in Own Shares
3rd Oct 20235:40 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.